Insights On Upstream Manufacturing
-
Scaling Up mAb Process Development To A 5L Bioreactor
4/10/2024
This study, conducted with cloud-connected bioreactors designed to accommodate CHO cells, showcases this technology transfer by comparing results obtained from shake flask cultures at various scales.
-
Instant Implementation Of Raman-Based Monitoring
4/9/2024
This platform, based on Raman technology with a de novo approach, operates as effortlessly as a pH-meter, providing real-time measurements of key process parameters such as glucose, lactate, and biomass.
-
Advancing 3D Cell Culture Models For Clinical Relevance
4/9/2024
Concerns about in vitro relevance and animal study limits have advanced cell culture tech. Explore how Organ-Chips offer a refined approach to studying human physiology.
-
Accelerating DNA To MCB To Generate High-Titer And High-Quality Cell Lines
4/8/2024
The goal of this study was to implement a high-throughput technology for the single cell cloning step, supporting improved clone outgrowth, early prediction of high producers, and fast clone expansion.
-
High-Throughput Media Optimization For CHO Cell Lines
4/8/2024
This study introduces a methodology that integrates data-rich experiments with advanced data analytics and can elevate mAB titer, enhance productivity, and help achieve key quality attributes.
-
Evaluating Cell Culture Medium Performance In CAR-T Processes
4/8/2024
This study examines the expansion, functionality, and phenotype of CAR-T cells cultured in the CellGenix® GMP T cell culture medium (TCM) compared to other commercially available T cell media.
-
Leveraging Perfusion Early In Process Development For Better Commercial Outcomes
4/5/2024
By addressing the complex needs of cell culture from the start, organizations can take steps to optimize their process, ensuring they are maximizing productivity and product quality.
-
Rev-Up AAV Genome Production In Upstream Manufacturing
3/28/2024
By increasing recombinant AAV titers, this AAV enhancer can help reduce upstream manufacturing costs and lower the cost per therapeutic dose.
-
A Solution To Automate Concentration, Washing, And Medium Exchange
3/27/2024
Experience the assurance and peace of mind that come from utilizing a solution crafted to support the optimization and reliability of your operations.
-
A Closed And Automated Solution To Streamline Your Workflow
3/27/2024
Whether it's dilution, mixing, cryopreparation, or splitting of cellular products, ReadySelect offers a comprehensive solution for your up- or downstream cell therapy manufacturing workflow.